Actions
Chicago
,
USA
18 - 22 April 2026
American Academy of Neurology Annual Meeting (AAN 2026)
Presentation schedule and materials
Monday, 20 April 2026
17:00
- 18:00
CDT
#006
POSTER
Results from evoke and evoke+: Two phase 3, randomised, placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer’s disease
Jeffrey L. Cummings1, Alireza Atri2–4, Howard H. Feldman5, Mary Sano6,7, Henrik Zetterberg8, Filip K. Knop9, Peter Johannsen9, Teresa León9, Rikke Mortensen Abschneider9, Philip Scheltens10,11
MATERIALS AVAILABLE
Coming soon
Actions
Keywords